PRKAB1/PRKAB2 Antikörper (C-Term)
Kurzübersicht für PRKAB1/PRKAB2 Antikörper (C-Term) (ABIN6735522)
Target
Reaktivität
Wirt
Klonalität
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Recognizes human AMPK- b1,2. Species cross-reactivity: mouse, rat and 100 % conserved in C. elegans F55F3.1. p protein (269-aa), Y47D3A.15. p protein (274-aa). Species sequence homology: Drosophila proteins CG8057 (341-aa), GH2668p (220-aa).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
A 15-aa peptide sequence mapping near the C-terminus of human AMPK-b1/2 (1) was synthesized, coupled to KLH.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
Applikationshinweise
-
Approved: ELISA (1:10000 - 1:100000), WB (1 - 10 μg/mL)
Usage: Suitable for use in ELISA, Western Blot. Western Blot: 1-10 μg/mL using ECL. ELISA: 1:10000-1:100000 using 50-100 ng of control peptide/well. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4 0.1 % BSA, 0.1 % sodium azide, 40 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- avoid freeze thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles.
-
-
- PRKAB1/PRKAB2 (Protein Kinase, AMP-Activated, beta 1/2 Non-Catalytic Subunit (PRKAB1/PRKAB2))
-
Andere Bezeichnung
- AMP Activated Protein Kinase Beta (PRKAB1/PRKAB2)
-
Pathways
- Warburg Effekt
Target
-